company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1237700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1237700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,419600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,419600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,818100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,480600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,139200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,25100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,644900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,173200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,164400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,128900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,128900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,128900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,111700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.15
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.1
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.15
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1321400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1321400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,399100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,399100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,922300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,508800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,175500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-63800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,620500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,301800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,304400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,75300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,229100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,229100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,229100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.95
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,325700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,325700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,98500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,98500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,227200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,126100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-38200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,132600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,94200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,335500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,335500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,101900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,101900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,233600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,128500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,172600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,61000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,62800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,47500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,47500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,392400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,392400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,113500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,113500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,278900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,142400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,55900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-8100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,200700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,78200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,70100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1447000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1447000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,408300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,408300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1038700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,550000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,204400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-8100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,22700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,769000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,269700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,268200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,50200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,218000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,218000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,218000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.92
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.83
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.92
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1054600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1054600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,294800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,294800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,759800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,407600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,148500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,12200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,568300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,191500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,198100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,44900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,153200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,153200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,153200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.35
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,348900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,348900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,95800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,95800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,253100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,133000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,189600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,66200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,705700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,705700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,199000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,199000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,506700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,274600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,95800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,8300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,378700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,128000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,131900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,105200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,105200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,105200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.93
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.93
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.93
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,365200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,365200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,100400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,100400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,264800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,140600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,8300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,199500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,65300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,66400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,57500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,57500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,57500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,340500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,340500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,98600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,98600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,241900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,134000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,179200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,62700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,65500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,47700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,47700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,430200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,430200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,119600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,119600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,310600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,163400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,17600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,236900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,73700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1678600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1678600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,489800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,489800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1188800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,642400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,246300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,21600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,905500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,283300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,283600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,236700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,236700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,236700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.07
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.98
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.07
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1248400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1248400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,370200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,370200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,878200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,479000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,185600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,668600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,209600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,215000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,173600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,173600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,173600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1640800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1640800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,483700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,483700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1157100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,621400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,241500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-8100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,14500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,869300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,287800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,285100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,238400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,238400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,238400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.08
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.08
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.08
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,412700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,412700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,125600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,125600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,287100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,165500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,61700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,227200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,59900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,57600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,51600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,51600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.45
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.45
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,835700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,835700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,244600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,244600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,591100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,313500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,123900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,441400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,149700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,157400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,122000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,122000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,122000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.06
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.06
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.06
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1577000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1577000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,453900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,453900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1123100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,588900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,232500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-8100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,18400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,831700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,291400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,293700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,58900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,234800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,234800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,234800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.05
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.05
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.05
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,431200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,431200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,127800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,127800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,303400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,163200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,64900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,232100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,71300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,72800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,58100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,58100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,58100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1511000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1511000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,426500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,426500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1084500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,566300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,218200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-8100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,22700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,799100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,285400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,287300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,53100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,234200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,234200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,234200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,404500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,404500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,116800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,116800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,287700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,150300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,209300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,78400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,84600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,510500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,510500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,122200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,122200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,388300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,170000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,74900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,23400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,269000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,119300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,119300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.78
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.78
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.78
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1899600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1899600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,491000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,491000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1408600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,697400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,291300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,30400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1020800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,387800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,388200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,96700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,291500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,291500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,291500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.54
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.46
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1389100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1389100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,368800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,368800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1020300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,527400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,216400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,751800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,268500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,268900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,66800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,202100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,202100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,202100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.75
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.75
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.75
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1819300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1819300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,488400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,488400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1330900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,690800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,277100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,24600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,988700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,342200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,337500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,72300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,265200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,265200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,265200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.29
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.29
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.29
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,447900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,447900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,111700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,111700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,336200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,167800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,73800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,243100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,93100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,93400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,69200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,69200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,941200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,941200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,257100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,257100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,684100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,359600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,142600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,508700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,175400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,175500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,42600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,132900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,132900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,132900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.16
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.16
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.16
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1784100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1784100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,502300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,502300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1281800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,688500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,265000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-5300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,24600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,972800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,309000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,301700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,54100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,247600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,247600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,247600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.15
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.15
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.15
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,482000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,482000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,129800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,129800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,352200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,182400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,74000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,262400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,89800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,89900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1733300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1733300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,500300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,500300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1233000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,669300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,255900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,21600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,942500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,290500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,284600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,237900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,237900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,237900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.09
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.09
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.09
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,459200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,459200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,127300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,127300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,331900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,177200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,246300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,85600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,85600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,65100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,65100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,65100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2045500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2045500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,516600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,516600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1528900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,733400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,323000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-45200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1012500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,516400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,511200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,122100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,389100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,389100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,389100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.74
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,227600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.71
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.74
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,536000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,536000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,143800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,143800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,392200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,186600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,78600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,23100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,287900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,104300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,100300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,75100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,75100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,75100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,227600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1509500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1509500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,372800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,372800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1136700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,546800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,244400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-68300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,724600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,412100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,410900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,96900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,314000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,314000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,314000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,111000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.83
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.83
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,111300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.83
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2020000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2020000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,495000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,495000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1525000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,716800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,319300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-44900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,993600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,531400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,530200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,126800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,403400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,403400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,403400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,111000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.63
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.63
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,111300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.63
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,495600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,495600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,128200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,128200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,367400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,177800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,84100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,266600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,100800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,99800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,23000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,76800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,76800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,111000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.69
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,111300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.69
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1013900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1013900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,244600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,244600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,769300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,369000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,160300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-72600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,458000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,311300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,311100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,73900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,237200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,237200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,237200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.11
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.11
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.11
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1972300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1972300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,478500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,478500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1493800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,706800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,309000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-49200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,970100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,523700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,523800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,128000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,395800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,395800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,395800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.52
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.52
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.52
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,517200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,517200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,123600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,123600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,393600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,186600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,80500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,272700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,120900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,120500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,93300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,93300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,93300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1937100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1937100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,484700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,484700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1452400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,702600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,302500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-47700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,959800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,492600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,493200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,122900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,370300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,370300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,370300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.25
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.25
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.25
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,496700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,496700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,121000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,121000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,375700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,182400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,79800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-78100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,185300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,190400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,190600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,143900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,143900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.26
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.24
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2322900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2322900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,625600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,625600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1697300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,858000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,346500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-669700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,534800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1162500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1144000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,332900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,811100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,811100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,811100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.81
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.74
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,212900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.81
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,618000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,618000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,160400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,160400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,457600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,223100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,84000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,315300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,142300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,132900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,23700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,109200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,109200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,109200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,212900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,607400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,607400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,168100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,168100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,439300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,222200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,87600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,316200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,123100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,120600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.89
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.87
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.89
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1704900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1704900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,465200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,465200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1239700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,634900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,262500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-680500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,219500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1020200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-9100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1011100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,309200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,701900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,701900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,701900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2240900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2240900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,609000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,609000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1631900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,821500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,341100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-657400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,507400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1124500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1111400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,334400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,777000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,777000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,777000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.3
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.3
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.3
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,575100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,575100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,151200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,151200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,423900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,215500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,89100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-697400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-392400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,816300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,813200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,266200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,547000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,547000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,547000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.18
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.09
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.18
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1097500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1097500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,297100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,297100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,800400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,412700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,174900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-684400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-96700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,897100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-6600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,890500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,283200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,607300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,607300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,607300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.75
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.75
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.75
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2129100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2129100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,569100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,569100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1560000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,777100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,337600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-657000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,457800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1102200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1090600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,331400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,759200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,759200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,759200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.19
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.19
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.19
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,522400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,522400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,145900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,145900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,376500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,197200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,85800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,13000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,295700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,80800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,77300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,60300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,60300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2071200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2071200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,541500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,541500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1529700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,748200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,329000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,45900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1122900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,406800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,397900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,92400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,305500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,305500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,305500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.86
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.86
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.86
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2493700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2493700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,617200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,617200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1876500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,850700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,382900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1240800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,635700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,622400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,127500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,494900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,494900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,494900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.3
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,220300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.25
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,215200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.3
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,671100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,671100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,175900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,175900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,495200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,222300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,98000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,325500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,169700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,167000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,140700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,140700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,140700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,220300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,215200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,615500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,615500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,146700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,146700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,468800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,212000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,101000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,313000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,155800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,150700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,118100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,118100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,118100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,214700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1822600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1822600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,441300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,441300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1381300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,628400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,284900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,915300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,466000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-6700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,455400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,101200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,354200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,354200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,354200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,214700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2440600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2440600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,601700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,601700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1838900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,851500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,368900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1230600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,608300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,588300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,124900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,463400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,463400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,463400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.15
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.15
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,214700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.15
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,616800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,616800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,158600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,158600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,458200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,213900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,97500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,313200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,145000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,142200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,216700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1207100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1207100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,294600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,294600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,912500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,416400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,183900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,602300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,310200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-4200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,304700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,236100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,236100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,236100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.1
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.1
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,216700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.1
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2432500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2432500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,623100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,623100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1809400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,861700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,355500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1233800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,575600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,558200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,118300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,439900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,439900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,439900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,216700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,590300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,590300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,136000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,136000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,454300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,202500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,86400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,289100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,165200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,162500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,39100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,123400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,123400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,123400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,220600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,216500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2390800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2390800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,615700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,615700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1775100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,863300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,347100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-682700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,528200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1246900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1229200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,355000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,874200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,874200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,874200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.06
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,220600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.06
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,216500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.06
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2963700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2963700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,797400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,797400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2166300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,904700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,442200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,68200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1415100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,751200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,737900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,168400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,569500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,569500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,569500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.67
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.61
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,213300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.67
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,767700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,767700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,554500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,233600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,353300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,201200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,200400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,158500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,158500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,158500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.74
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,213300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,739400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,739400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,201400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,201400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,538000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,229600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,113000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,6600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,349200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,188800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,185200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,43800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,141400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,141400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,141400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.66
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,218100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,214200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.66
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2196000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2196000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,584200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,584200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1611800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,671100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,327300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,63400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1061800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,550000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,537500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,126500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,411000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,411000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,411000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.93
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,218100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.93
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,214200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.93
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2867100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2867100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,760100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,760100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2107000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,893400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,425300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,70600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1387300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,719700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,704500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,152800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,551700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,551700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,551700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.59
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,218100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.59
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,214200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.59
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,759300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,759300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,202500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,202500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,556800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,228800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,112500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,44000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,385300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,171500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,169000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,42400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,126600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,126600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,126600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,212200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1456600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1456600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,382800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,382800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1073800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,441500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,214300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,56800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,712600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,361200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,352300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,82700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,269600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,269600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,269600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,212200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.27
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.27
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2743200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2743200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,705400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,705400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2037800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,875800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,413300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,64000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1351100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,686700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,670000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,141600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,528400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,528400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,528400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,212200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.49
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.49
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.49
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,697300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,697300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,180300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,180300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,517000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,212700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,101800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,12800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,327300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,189700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,183300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,40300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,143000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,143000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.67
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.66
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,213400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.67
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2600700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2600700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,661500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,661500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1939200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,860900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,398300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,20000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1279000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,660200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,643200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,128700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,514500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,514500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,514500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.41
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.41
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,213400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.41
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3435300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3435300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,875300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,875300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2560000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,990800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,552600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1470600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1089400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-51600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-54500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1034900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,451300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,583600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,583600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,583600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,210900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.77
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.7
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.77
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,888500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,888500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,235300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,235300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,653200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,272800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,146600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-9700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-92600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,317100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,336100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,323900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,326700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,210900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,821500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,821500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,213300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,213300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,608200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,244600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,142900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,394200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,214000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,211800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,216200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2546800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2546800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,640000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,640000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1906800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,718000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,406000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,19100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1153500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,753300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-38400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-42300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,711000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,124600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,586400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,586400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,586400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.78
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,216200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.78
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.78
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3314500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3314500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,853200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,853200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2461300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,951600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,520900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,23900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1506800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,954500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-37700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-43100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,911400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,166500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,744900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,744900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,744900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.53
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,216200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.53
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.53
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,841800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,841800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,211100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,211100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,630700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,243800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,134400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,389700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,241000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,205600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,186100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,186100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,186100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,210500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.86
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.88
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1725300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1725300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,426700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,426700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1298600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,473400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,263100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,22100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,759300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,539300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-36300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-40100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,499200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,82900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,416300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,416300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,416300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,210500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.98
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.98
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.98
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3232400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3232400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,841300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,841300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2391100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,936600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,491000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,33500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1461800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,929300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-37100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-44500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,884800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,168600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,716200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,716200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,716200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,210500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.4
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.4
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.4
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,883500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,883500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,215600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,215600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,667900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,229600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,128700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,11300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,369600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,298300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,293600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,63400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,230200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,230200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,230200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.09
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,216400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.06
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.09
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3149900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3149900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,832700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,832700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2317200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,921600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,469100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,66700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1457400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,859800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,848200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,191500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,656700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,656700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,656700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.11
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,216400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.11
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.11
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3722800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3722800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,939400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,939400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2783400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1088500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,622200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,324500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2035200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,748200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,761400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,39200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,722200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,722200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,722200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.45
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,213600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.38
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.45
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,977700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,977700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,234700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,234700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,743000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,288100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,163100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,297100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,748300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,30200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,213600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,906600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,906600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,224900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,224900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,681700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,269500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,161800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,432800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,248900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,248700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.08
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.06
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.08
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2745100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2745100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,704700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,704700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2040400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,800400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,459100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,27400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1286900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,753500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,763200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,715200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,715200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,715200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.41
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.34
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.41
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3633600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3633600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,940000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,940000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2693600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1073200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,605700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-9700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-65200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1604000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1089600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1087100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,374700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,712400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,712400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,712400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.41
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.41
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.41
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,943700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,943700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,246200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,246200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,697500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,274900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,154100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,16400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,445400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,252100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,251000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-31700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,282700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,282700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,282700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,214000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.32
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1838500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1838500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,479800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,479800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1358700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,530900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,297300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,25900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,854100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,504600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,514500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,489300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,489300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,489300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.33
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,214000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.28
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.33
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3548500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3548500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,928400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,928400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2620100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1048300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,586800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-69700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1565400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1054700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1050200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,393600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,656600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,656600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,656600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.13
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,214000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.13
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.13
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,894800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,894800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,233600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,233600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,661200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,256000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,143200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,9500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,408700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,252500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,263500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,56900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,206600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,206600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,206600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,210200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.98
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.96
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.98
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3446600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3446600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,893300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,893300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2553300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1017200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,567100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-75300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1509700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1043600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-39100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-38800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1004800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,444800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,560000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,560000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,560000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,210200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.66
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.66
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.66
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1174100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1174100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,286200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,286200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,887900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,347200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,193900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,36000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,577100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,310800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,315500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,280200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,280200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,280200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.31
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4348000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4348000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1114400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1114400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3233600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1242200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,752700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,91900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2086800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1146800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,19700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1166500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,119600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1046900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1046900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1046900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.03
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.93
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.03
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3173900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3173900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,828200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,828200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2345700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,895000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,558800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,55900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1509700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,836000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-7200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,851000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,84300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,766700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,766700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,766700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.68
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.62
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.68
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4151600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4151600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1062900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1062900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3088700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1183100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,721900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,353000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2258000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,830700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,18500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,849200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,75500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,773700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,773700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,773700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.72
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.66
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.72
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1094000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1094000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,292400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,292400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,801600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,306200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,195500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,507300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,294300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,301700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.32
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.3
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.32
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2079900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2079900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,535800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,535800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1544100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,588800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,363300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,50300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1002400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,541700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,549300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,57300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,492000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,492000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,492000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.36
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.32
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.36
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3964200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3964200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,995400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,995400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2968800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1146400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,688200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,348900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2183500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,785300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,796200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,71300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,724900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,724900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,724900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.48
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.48
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1086900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1086900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,304000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,304000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,782900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,308500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,191900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,15000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,515400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,267500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,271300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,242300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,242300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,242300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.16
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.14
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.16
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,993000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,993000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,231800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,231800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,761200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,280300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,171400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,35300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,487000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,274200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,278000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,207900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.2
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.18
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.2
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3821000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3821000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,937600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,937600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2883400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1112800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,650400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,350300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2113500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,769900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,28700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,775900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,765300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,765300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,765300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,207900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.67
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.67
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4483700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4483700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1147700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1147700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3336000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1269700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,768700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,66900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2105300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1230700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,22300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1253000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,145200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1107800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1107800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1107800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.32
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,211700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.22
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.32
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1128700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1128700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,265100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,265100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,863600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,307800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,187400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,505500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,358100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-4500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,364500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,53900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,310600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,310600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,310600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.49
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,211700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.47
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.49
